GLTO: Galecto, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.27
Enterprise Value ($M) -1.82
Book Value ($M) 28.16
Book Value / Share 1.04
Price / Book 0.68
NCAV ($M) 26.22
NCAV / Share 0.97
Price / NCAV 0.73

Profitability (mra)
Return on Invested Capital (ROIC) -1.09
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio 7.07
Current Ratio 7.07

Balance Sheet (mrq) ($M)
Current Assets 30.54
Assets 32.48
Liabilities 4.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -36.46
Net Income -38.35

Cash Flow Statement (mra) ($M)
Cash From Operations -36.91
Cash from Investing 22.33
Cash from Financing 2.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-03 13G Otto Erik 6.70
09-18 13D/A Orbimed Advisors Llc 2.80 -34.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 2,405 22,888 10.51
2024-05-02 36,694 46,784 78.43
2024-05-01 3,460 10,178 33.99
2024-04-30 36,975 48,317 76.53
2024-04-29 9,902 14,473 68.42

(click for more detail)

Similar Companies
GHSI – Guardion Health Sciences, Inc. GLMD – Galmed Pharmaceuticals Ltd.
GLSI – Greenwich LifeSciences, Inc. GNLX – Genelux Corporation
GNPX – Genprex, Inc.


Financial data and stock pages provided by
Fintel.io